0
2020
Inhalation Anesthesia Market

Inhalation Anesthesia Market

by Product (Sevoflurane, Desflurane, Isoflurane, and Nitrous Oxide), Application (Induction and Maintenance), and End-User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2019-2026
Update Available On-Demand

Report Code: A06080
Pages: 165
Mar 2020 | 4592 Views
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 110
Charts: 28
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Inhalation Anesthesia Market

Request Now !

The global inhalation anesthesia market was valued at $1,137 million in 2018 and is expected to reach $1,549 million by 2026, registering a CAGR of 4.2% from 2019 to 2026. Anesthetic agents are used during surgical procedures to control pain, breathing, blood pressure, blood flow, and heart rate & rhythm. Inhalational anesthesia is primarily used for the induction of general anesthesia and sedation purposes. The most widely used inhalational anesthetics are sevoflurane, desflurane, and nitrous oxide. Inhalational anesthetics usually result in respiratory depression, reduction in arterial blood pressure and cerebral metabolic demand, and rise in cerebral blood flow. The most common side effect of inhalation anesthesia is nausea. 

Inhalation Anesthesia Market

Significant rise in the number of emergency incidences and road accidents; surge in prevalence of various disorders such as cancer, respiratory diseases, and gastrointestinal disorders; upsurge in number of surgical procedures; and increased use of these in various disease diagnosis drive the inhalation anesthesia market growth. Further, there is an increase in incidence of various chronic diseases such as cancer, infectious diseases, and genetic disorders worldwide. According to the WHO, cancer is one of the leading causes of morbidity and mortality worldwide, with about 18 million cases in 2018 alone, and id expected to increase by about 70% over the next two decades. Infections known to be caused by strains of cancer are most prominent in low- and middle-income countries. In addition, factors such as innovations in these inhalation devices and governmental support regarding the use of inhalation anesthetics further fuel the market growth. However, risks associated with certain therapeutic and diagnostic devices for neonates and low adoption rate of new technologies, owing to reluctance from physicians for treatment, restrain the growth of the inhalation anesthesia devices market. In addition, environmental concerns regarding vigorous usage of inhalation anesthesia is anticipated to hamper the market growth. In addition, current trend in FDA drug approval exhibits drastic drop in pharmaceutical approvals compared to earlier authorizations, as FDA issued more rejections than typical rejections in past few years. Moreover, stringent regulations set by FDA in surgical procedures also hinder the growth of the inhalation anesthesia market. Moreover, significant rise in elderly population and increase in healthcare expenditures in developing economies are anticipated to provide lucrative growth opportunities for the market. In addition, emerging economies of Asia-Pacific and LAMEA offer lucrative growth opportunities for the expansion of inhalation anesthesia market, due to improvement in healthcare infrastructure and increase in demand for better healthcare. In addition, rise in incidences of road accidents, surgical procedures, and various diseases such as cancer and gastrointestinal disorders boost the demand for inhalation anesthesia.

Global Inhalation Anesthesia Market Segmentation

The market is segmented on the basis of product, application, end user, and region. By product it is segmented into sevoflurane, desflurane, isoflurane, and nitrous oxide. On the basis of application, it is bifurcated into induction and maintenance. By end user it is classified into hospitals and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Inhalation Anesthesia Market
By Product

Your browser does not support the canvas element.

Desflurane segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Product segment review

By product, the sevoflurane segment accounted for majority of the market share in 2018 and is expected to exhibit a prominent growth rate in the near future. This is attributed to several advantages offered by it, such as favorable blood gas solubility coefficient and pleasant odor.

Inhalation Anesthesia Market
By Application

Your browser does not support the canvas element.

Maintenance segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Application segment review

By application, the maintenance segment dominated the inhalation anesthesia market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased usage of inhalation anesthesia for maintenance of general anesthesia as they enable a more specific control of the anesthetic state at a low cost.

Inhalation Anesthesia Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.0% during 2019-2026.

Get more information on this report : Request Sample Pages

Region wise, North America held the largest share in the inhalation anesthesia market in 2018, followed by Europe. The factors that drive the overall growth of the North America inhalation anesthesia market include increase in government funds for R&D of novel inhalation anesthesia as well as surge in incidences of cancer. Furthermore, rise in prevalence of diseases and surgical procedures carried out for disease treatment and development fuel the market growth. However, Asia-Pacific is anticipated to grow at the highest rate during the analysis period. This is attributed to increase in disorders, such as cancer and respiratory disorders, that often require surgery. Moreover, the market growth in this region is supplemented by increase in demand for healthcare infrastructure, rise in number of hospitals in emerging countries, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare

Comprehensive competitive analysis and profiles of major market players AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA., Halocarbon Products Corporation, Hikma Pharmaceuticals PLC., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd, Novartis AG, Piramal Enterprises Ltd, and Troikaa Pharmaceuticals Ltd are provided in this report.

Key Benefits for Stakeholders:

  • The inhalation anesthesia market share and analysis is based on a comprehensive analysis of key developments in the inhalation anesthesia industry.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
  • The global inhalation anesthesia market trends are studied from 2018 to 2026.
  • Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
  • The quantitative analysis of the global inhalation anesthesia market from 2019 to 2026 is provided to determine the market potential.

Inhalation Anesthesia Market Report Highlights

Aspects Details
By Product
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
By Application
  • Induction
  • Maintenance
By End User
  • Hospitals
  • Ambulatory Surgical Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia Pacific  (Japan, China, India, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players ABBVIE INC., BAXTER INTERNATIONAL INC., Fresenius SE & Co. KGaA, Halocarbon Products Corporation., Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., Novartis AG., Piramal Enterprises Ltd., Troikaa Pharmaceuticals, Ltd.
 

Loading Table Of Content...


 
 

Inhalational anesthesia is a chemical compound compromising general anesthetic properties that can be delivered via inhalation. The inhalation anesthesia market is expected to witness a significant growth in the future as it has gained the interest of the healthcare industry, owing to increase in prevalence of various disorders and surgical procedures globally.

The inhalation anesthetics is an established technology; hence, is expected to experience an increase in adoption rate. In addition, technological advancements are prevalent in the market, thus there is rise in the number of product launches, due to which the market is estimated to grow with a high growth rate. Furthermore, increase in demand for quality healthcare products around the globe is expected to drive the market growth. Technological advancements and prevalence of diseases, such as cancer, fuel the growth of the market. Key market players are continuously focusing toward new product development to provide surgical assistance to surgeons and doctors for prolonged sophisticated surgical procedures. North America accounts for the maximum market share, owing to the highest adoption of inhalation anesthetics in the region, which is expected to follow the same trend during the forecast period. However, Asia-Pacific is anticipated to grow at the fastest growth rate during the forecast period, owing to considerable increase in the number of hospitals and surgical procedures.  

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The market vaule of global Inhalation Anesthesias market was $1,137 million in 2018.

A. The forecast period is from 2019 to 2026.

A. The market value of global Inhalation Anesthesia market in 2019 is $1,160 million.

A. The adoption of Inhalation Anesthesia is expected to increase due to rise in various surgical processes and surge in road accident incidences.

A. No, the report does not provides value chain analysis.

A. Introduction of various compunds that possess lesser side effects.

A. Emerging countries of Asia-Pacific region are growing at a growth rate of 6.0%. China, Australia, are expected grow at a CAGR of 6.6% and 6.3% respectively.

A. The North America market held a major share in the Inhalation Anesthesias market in 2018 and is expected to continue the trend in the forecasting period.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Inhalation Anesthesia Market

Start reading instantly.
This Report and over 18,746+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2021 - Mar 2022)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2021 - Mar 2022)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2021 - Mar 2022)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2021 - Mar 2022)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2021 - Mar 2022)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers